SmithKline Beckman Corp open 8.5 mln dlr pharmaceutical manufacturing plant Tianjin China. The plant pharmaceutical product joint venture company Tianjin Smith Kline French Laboratories. SmithKline joint venture combine Smith Kline French Laboratories pharmaceutical unit SmithKline Beckman Tianjin Medical Co> Hebel Chemical Plant> Tianjin. The plant capability produce billion tablet 200 mln capsule year. Reuter 